Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA testing. In order to conserve the remaining reagent, a controlled process of batch testing was implemented. Therefore, you will likely see additional delays in receiving these supplemental test results.
Read about our plan to mitigate this on the Communications page by clicking this link: Communications
Creative Testing Solutions, the largest nonprofit blood testing organization in the U.S., today anno...
On July 6, 2018 the FDA released an industry guidance document for transitioning from individual to ...
CTS will be transitioning to a new sFTP server for clients who send test request and/or receive...
As winter weather continues to move through parts of the US, we would like to remind you it may be n...
On June 13, 2019, CTS provided information regarding the manufacturer’s discontinuation of HIV...
Reminder - On Wednesday June 6, 2018 at 10:00AM PST, we will be hosting a webinar regarding the chan...